Biotransformation of sevoflurane in dogs and rats
- PMID: 6782910
Biotransformation of sevoflurane in dogs and rats
Abstract
Sevoflurane, 3% and 4% in oxygen was administered to four dogs for 3 hours. Sevoflurane was metabolized to inorganic fluoride and hexafluoroisopropanol. Serum fluoride concentrations reached peak values during 2 to 3 hours into anesthesia and averaged 18.5 micrometer/L (n = 2) and 20.0 +/- 4.8 (mean +/- SD) micrometer/L (n = 4) following 3% and 4% sevoflurane exposure, respectively. They returned to normal values within 24 hours after anesthesia. Hexafluoroisopropanol was excreted in the urine as glucuronide conjugate. Its elimination was essentially complete within 48 hours after the end of exposure to sevoflurane. During inhalation of 4% sevoflurane, blood concentration of the anesthetic reached an average apparent steady state of 0.765 +/- 0.10 micrometer/L (n = 4). No anesthetic was detected in blood 24 hours after this exposure. Rats were anesthetized with 2% sevoflurane for 2 and 4 hours. Immediately after anesthesia, observed mean (n = 6) serum fluoride concentrations were 2.9 +/- 0.5 micrometer/L and 2.5 +/- 0.6 micrometer/L, respectively. Hepatic microsomal enzyme induction produced by pretreatment with either phenobarbital or polychlorinated biphenyls (PCBs) resulted in an approximately 5-fold increase in serum fluoride concentrations following anesthesia with sevoflurane when compared to noninduced rats exposed to sevoflurane. A comparison of serum fluoride concentrations between the rat and dog indicates that the amount of sevoflurane metabolized is lower in the rat than in the dog, and the fluoride concentrations observed in both animal species during sevoflurane anesthesia are not expected to produce nephrotoxicity.
Similar articles
-
Renal safety and extrahepatic defluorination of sevoflurane in hepatic transplantations.Transplant Proc. 2007 Jun;39(5):1544-8. doi: 10.1016/j.transproceed.2007.01.081. Transplant Proc. 2007. PMID: 17580185
-
Dose-related sevoflurane metabolism to inorganic fluoride in rabbits.Hiroshima J Med Sci. 1991 Mar;40(1):1-7. Hiroshima J Med Sci. 1991. PMID: 1864761
-
Metabolism and toxicity of the new anesthetic agents.Acta Anaesthesiol Belg. 1996;47(1):7-14. Acta Anaesthesiol Belg. 1996. PMID: 8651050 Review.
-
Effect of phenytoin (DPH) treatment on methoxyflurane metabolism in rats.J Pharmacol Exp Ther. 1979 Aug;210(2):180-5. J Pharmacol Exp Ther. 1979. PMID: 458627
-
Biotransformation of sevoflurane.Anesth Analg. 1995 Dec;81(6 Suppl):S27-38. doi: 10.1097/00000539-199512001-00005. Anesth Analg. 1995. PMID: 7486145 Review.
Cited by
-
Exposure of neonatal mice to Sevoflurane may induce male germ cell apoptosis in testicular tissue after puberty.Int J Reprod Biomed. 2017 Aug;15(8):471-478. Int J Reprod Biomed. 2017. PMID: 29082365 Free PMC article.
-
Sevoflurane. A review of its pharmacodynamic and pharmacokinetic properties and its clinical use in general anaesthesia.Drugs. 1996 Apr;51(4):658-700. doi: 10.2165/00003495-199651040-00009. Drugs. 1996. PMID: 8706599 Review.
-
Correlation between renal function and pharmacokinetic parameters of inorganic fluoride following sevoflurane anesthesia.J Anesth. 1995 Jun;9(2):125-128. doi: 10.1007/BF02479842. J Anesth. 1995. PMID: 28921279
-
Sevoflurane and its metabolic byproduct compound A induce nephrotoxicity: a systematic review and meta-analysis of animal studies.Med Gas Res. 2025 Jun 1;15(2):254-265. doi: 10.4103/mgr.MEDGASRES-D-24-00080. Epub 2025 Jan 18. Med Gas Res. 2025. PMID: 39829162 Free PMC article.
-
Changing practices in neuroanaesthesia.Can J Anaesth. 1990 May;37(4 Pt 2):Slxxxix-Scvii. doi: 10.1007/BF03006278. Can J Anaesth. 1990. PMID: 2193724 Review. English, French. No abstract available.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources